Lexicon Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing precision medicines for serious chronic conditions. The company markets Xermelo for carcinoid syndrome diarrhea and has a pipeline addressing cardiovascular, metabolism, and other therapeutic areas. Lexicon utilizes its proprietary gene knockout technology platform to identify and validate novel drug targets.